Research assistance

We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 

Matching geography

Reports matching your search in:
 
 

Join Alert Me now!

Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology: market research reports

1594

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides.
In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology market research reports and industry analysis

< prev 1  2  3  4  5  6  7  8  9  10  next >
Biomaterials China News 1211
11/8/2012 | published by: CCM International Limited
... have been constructed recently. Besides, PBS is considered as a good opportunity for traditional oil and coal chemical enterprises to transfer upstream cost and gain high added value though current market may be not mature ...  |  more...
$2,511.00
Plunkett's Health Care Technologies Overview 2013: A Summary Excerpted from Plunkett's Health Care Industry Almanac 2013
11/7/2012 | published by: Plunkett Research, Ltd.
... Online Link to our 5-minute video overview of this industry Pages: 77 Statistical Tables Provided: 39 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2013, including forecasts and ...  |  more...
$199.99
Plunkett's Health Care Industry Almanac 2013: Health Care Industry Market Research, Statistics, Trends & Leading Companies
11/7/2012 | published by: Plunkett Research, Ltd.
... Industry Glossary Buyer may register for access to search and export data at Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 694 Statistical Tables Provided: 39 Companies Profiled: 468 Geographic ...  |  more...
$349.99
Medical Research in China
11/7/2012 | published by: IBISWorld
... and biotech firms. The following research functions are not included in the industry: R&D activities by pharmaceutical or medical equipment manufacturing industries; research unrelated to the human body or human diseases; and the commercialization of ...  |  more...
$910.00
Plunkett's Health Care Industry Trends & Statistics 2013: A Summary Version of Plunkett's Health Care Industry Almanac 2013
11/7/2012 | published by: Plunkett Research, Ltd.
... Plunkett Research Online Link to our 5-minute video overview of this industry Pages: 76 Statistical Tables Provided: 39 Geographic Focus: Global A condensed market research report excerpted from Plunkett’s Health Care Industry Almanac 2013, including ...  |  more...
$199.99
Charles River Laboratories International, Inc. (CRL) - Financial and Strategic SWOT Analysis Review
11/6/2012 | published by: GlobalData
... Models and Services (RMS) and Preclinical Services (PCS). It offers drug development solutions which comprises research models and associated services, and outsourced preclinical services. Charles River focuses on providing solutions targeted against therapeutic areas of ...  |  more...
$125.00
Hernia Repair Device Markets and Procedures
11/6/2012 | published by: Kalorama Information
... are consistent from year to year. This report, Hernia Repair Device Markets and Procedures looks at the hernia repair industry segment. New product innovation, a steady demand for superior products by surgeons, and increasing procedure ...  |  more...
$3,995.00
Martek Biosciences Corporation : Ingredients - Company Profile, SWOT & Financial Report
11/2/2012 | published by: Canadean Ltd
... products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, key employees, company locations and subsidiaries, employee biographies as well as competitive benchmarking data. Summary This report is a crucial resource ...  |  more...
$125.00
Triple Analysis: Angiogenesis, Protein Kinase Inhibitors and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
Triple Analysis: Leukemia, Cancer Vaccines and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ...  |  more...
$5,175.00
Triple Analysis: Leukemia, Pancreatic Cancer and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Regenerative Medicine
11/1/2012 | published by: Global Industry Analysts
... 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as BioVest International, Inc., Curis, Inc., Cytori Therapeutics, Inc., Evotec ...  |  more...
$4,950.00
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
Analytical Tool - Cancer Therapeutic Antibodies
11/1/2012 | published by: BioSeeker Group AB
... time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current ...  |  more...
$5,923.50
Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ...  |  more...
$5,175.00
Triple Analysis: Lymphoma, Pancreatic Cancer and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ...  |  more...
$5,175.00
Triple Analysis: Pancreatic Cancer, Cancer Vaccines and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ...  |  more...
$5,175.00
Triple Analysis: Pancreatic Cancer, Prostate Cancer and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ...  |  more...
$5,175.00
US Prenatal Testing Market Report: 2012 Edition
11/1/2012 | published by: Koncept Analytics
... issues emanating from the changing lifestyle and continuously changing surroundings. To address the growing demand for better diagnosis and treatment options and the unmet needs within the chromosomal abnormalities and genetic disorders segment, respective companies ...  |  more...
$800.00
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
11/1/2012 | published by: BioSeeker Group AB
... evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer ...  |  more...
$5,175.00
< prev 1  2  3  4  5  6  7  8  9  10  next >